Workforce report to Congress, mandated by 21st Century Cures Act, details FDA's plans for implementing its new authorities provided by the law.
As the US FDA is preparing to face a slew of senior staffers reaching full retirement eligibility in the coming years, the agency's first point of implementation of hiring authorities from the 21st Century Cures Act will focus on supervisory and executive positions across the medical product centers.
Compounding FDA's ability to staff leadership positions within the Center for Drug Evaluation and Research (CDER), the Center for Biologics...
The Health and Human Services Secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.
HHS and its agencies violated the law by swiftly implementing “sweeping and poorly thought-through directives that ordered the bulk removal of healthcare resources,” including FDA draft guidances on diversity action plans and sex differences in clinical trials, a federal court said.
Industry associations EFPIA, EUCOPE and EURORDIS have praised the European Commission’s newly launched life sciences strategy, which will see investment funnelled into improving the clinical trial ecosystem and supporting advanced therapy development.
